繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

健康催化剂2026年第一季度盈利预览

2026-05-11 05:35

  • Health Catalyst (HCAT) is scheduled to announce Q1 earnings results on Monday, May 11th, after market close.
  • The consensus EPS Estimate is $0.02 (+100.0% Y/Y) and the consensus Revenue Estimate is $69.19M (-12.9% Y/Y).
  • Over the last 2 years, HCAT has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
  • Over the last 3 months, EPS estimates have seen 0 upward revisions and 5 downward. Revenue estimates have seen 0 upward revisions and 8 downward.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。